Dan Barouch, told ABC News in late May that the pharmaceutical companies have an economic incentive and that a decision on booster shots should be made based on public health solely and not on economic incentives of the companies. Read Article
About Morgana Souza
This author has not written his bio yet.
But we are proud to say that Morgana Souza contributed 213 entries already.
Entries by Morgana Souza
The Johnson & Johnson vaccine appears to provide strong protection against the Delta variant that not only doesn’t wane over time but seems to grow stronger. See Article
The Johnson & Johnson coronavirus vaccine provides immunity that lasts at least eight months, and it appears to provide adequate protection against the worrying Delta variant, the company said in a statement Thursday night. Read Article
Johnson & Johnson announced that its COVID-19 vaccine “”generated strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent SARS-CoV-2 viral variants.” The vaccine was developed in a collaboration between Johnson & Johnson and BIDMC, led by Dan Barouch. Read Article
Johnson & Johnson said that its single-shot coronavirus vaccine neutralizes the fast-spreading delta variant and provides durable protection against infection more broadly. Read Article
The vaccine also produced long-lasting immune responses, researchers said. Booster shots seem unnecessary, at least for now. Read Article
After months of research, experts are seeing positive results. Read Article
The emergence of new and more infectious variants of the coronavirus has raised a troubling question: Will the current crop of COVID-19 vaccine prevent these variants from causing disease? Listen here
Johnson & Johnson’s COVID-19 vaccine triggers several types of immune responses, a new study shows, allowing it to be extremely protective in the United States as well as in South Africa and Brazil, where a handful of different virus variants are circulating. Read Article.
Center for Virology and Vaccine Research
3 Blackfan Circle
Boston, MA 02115 – USA
CVVR Clinical Trials Unit